Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
Conditions
Prostate Cancer
Conditions: official terms
Prostatic Neoplasms
Conditions: Keywords
prostate cancer
Study Type
Observational
Study Phase
N/A
Study Design
N/A
Intervention
Name: polymorphism analysis Type: Genetic
Name: laboratory biomarker analysis Type: Other
Name: questionnaire administration Type: Other
Overall Status
Recruiting
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This study is looking at genetic susceptibility and the interactions between genes and the environment in patients with prostate cancer.
Detailed Description
OBJECTIVES:

- To obtain epidemiological information and biological material on a population-based series of prostate cancer cases.

- To identify novel cancer susceptibility genes by comparison of genotype frequencies in cases with the corresponding frequencies in large control series.

- To estimate the age and sex-specific risks associated with variants in predisposition genes.

- To evaluate interactions between polymorphisms in predisposition genes and potential lifestyle risk factors.

OUTLINE: This is a multicenter study.

Patients complete a detailed epidemiological questionnaire, including information on education, occupation, smoking habits, alcohol consumption, height, weight, family history of cancer, and past medical history.

Blood samples are collected from patients. DNA is extracted from these blood samples and from samples collected from cancer-free control participants in MREC-SEARCH-CONTROL as well as from additional controls through the European Prospective Investigation of Cancer (EPIC) study (a population based study of diet and health based in Norfolk, East Anglia). DNA samples are analyzed for polymorphisms of low penetrance cancer susceptibility genes.

In addition to the prostate cancer patients recruited for this study, patients with breast, ovarian, endometrial, colorectal, bladder, kidney, pancreatic, brain and esophageal cancer, malignant melanoma, and lymphoma cancer are recruited in the following related clinical trials: MREC-SEARCH-BREAST, MREC-SEARCH-OVARIAN, MREC-SEARCH-ENDOMETRIAL, MREC-SEARCH-COLORECTAL, and MREC-SEARCH-CANCER.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 74 Years
Minimum Age: 18 Years
Gender: Male
Criteria: DISEASE CHARACTERISTICS:

- Diagnosis of prostate cancer within the past 5 years

- Identified through the cancer registry serving any of the following geographic regions of the United Kingdom:

- East Anglia

- Trent

- West Midlands

PATIENT CHARACTERISTICS:

- Identified by the patient's general practitioner as fit to contact for this study

- No serious mental illness or retardation

PRIOR CONCURRENT THERAPY:

- Not specified
Location
University of Cambridge Cancer Research UK
Cambridge, England, United Kingdom
Status: Recruiting
Contact: Contact Person - 44-122-374-0166 - paul.pharoah@srl.cam.ac.uk
Start Date
February 2008
Sponsors
Cancer Research UK
Source
National Cancer Institute (NCI)
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page